Pixelgen Technologies develops DNA-based tools for analyzing cell surface proteins.
Founded in 2020 and based in Stockholm, Sweden, Pixelgen Technologies develops spatial proteomics products. Its Molecular Pixelation technology uses DNA to visualize cell surface proteins, and the company also provides reagents and data analysis tools. In August 2026, it raised SEK 150 million in Series B funding led by Flat Capital, with participation from Industrifonden and Navigare Ventures. The company plans to use the funds to commercialize its Proxiome Kit globally and expand its team and product portfolio.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in